Amanda L. Bergner

2.6k total citations
32 papers, 640 citations indexed

About

Amanda L. Bergner is a scholar working on Genetics, Neurology and Epidemiology. According to data from OpenAlex, Amanda L. Bergner has authored 32 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 11 papers in Neurology and 7 papers in Epidemiology. Recurrent topics in Amanda L. Bergner's work include Genomics and Rare Diseases (11 papers), Neurofibromatosis and Schwannoma Cases (10 papers) and Meningioma and schwannoma management (7 papers). Amanda L. Bergner is often cited by papers focused on Genomics and Rare Diseases (11 papers), Neurofibromatosis and Schwannoma Cases (10 papers) and Meningioma and schwannoma management (7 papers). Amanda L. Bergner collaborates with scholars based in United States, Canada and United Kingdom. Amanda L. Bergner's co-authors include Jaishri O. Blakeley, Xiaobu Ye, Juli Bollinger, Cynthia A. James, Vanessa L. Merker, Scott R. Plotkin, Louise Bier, Thierry A.G.M. Huisman, Aylin Tekes and Lori C. Jordan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Amanda L. Bergner

31 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda L. Bergner United States 14 244 227 138 101 70 32 640
Tracy L. Trotter United States 13 105 0.4× 400 1.8× 91 0.7× 137 1.4× 141 2.0× 19 821
Anuradha Ganesh Oman 19 85 0.3× 153 0.7× 113 0.8× 241 2.4× 126 1.8× 98 948
Thomas Morel Belgium 11 159 0.7× 81 0.4× 51 0.4× 50 0.5× 63 0.9× 32 634
Winifred J. Hamilton United States 16 355 1.5× 195 0.9× 51 0.4× 256 2.5× 57 0.8× 22 904
André B. Rietman Netherlands 16 227 0.9× 231 1.0× 174 1.3× 194 1.9× 134 1.9× 61 926
F. Albarel France 17 147 0.6× 220 1.0× 196 1.4× 223 2.2× 82 1.2× 51 1.3k
Heidi Crayton United States 8 219 0.9× 74 0.3× 101 0.7× 86 0.9× 13 0.2× 12 1.0k
Michael van Trotsenburg Austria 14 58 0.2× 74 0.3× 75 0.5× 145 1.4× 39 0.6× 18 819
Melissa W. Ko United States 13 590 2.4× 88 0.4× 53 0.4× 61 0.6× 19 0.3× 29 816
Qinglin Pei United States 16 217 0.9× 114 0.5× 66 0.5× 127 1.3× 132 1.9× 59 786

Countries citing papers authored by Amanda L. Bergner

Since Specialization
Citations

This map shows the geographic impact of Amanda L. Bergner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda L. Bergner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda L. Bergner more than expected).

Fields of papers citing papers by Amanda L. Bergner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda L. Bergner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda L. Bergner. The network helps show where Amanda L. Bergner may publish in the future.

Co-authorship network of co-authors of Amanda L. Bergner

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda L. Bergner. A scholar is included among the top collaborators of Amanda L. Bergner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda L. Bergner. Amanda L. Bergner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergner, Amanda L., et al.. (2025). Barriers to the implementation of epilepsy genetic testing and counseling guidelines. Epilepsia Open. 10(5). 1595–1604.
2.
McElhiney, Martin, et al.. (2024). Individuals' experiences in genetic counseling and predictive testing for familial amyotrophic lateral sclerosis. Journal of Genetic Counseling. 34(1). e1890–e1890. 3 indexed citations
3.
Bergner, Amanda L., et al.. (2023). The utility of limited Spanish proficiency in interpreted genetic counseling sessions. Journal of Genetic Counseling. 32(3). 663–673. 1 indexed citations
4.
Choi, Hyunmi, Karolynn Siegel, Wendy K. Chung, et al.. (2023). Knowledge and beliefs about epilepsy genetics among Hispanic and non‐Hispanic patients. Epilepsia. 64(9). 2443–2453. 3 indexed citations
5.
Freiman, Andrew, et al.. (2023). Exploring the evolving roles of clinical geneticists and genetic counselors in the era of genomic medicine. American Journal of Medical Genetics Part A. 194(4). e63502–e63502. 1 indexed citations
6.
Liang, Lusha W., et al.. (2023). Patient experiences in receiving telegenetics care for inherited cardiovascular diseases. Journal of Community Genetics. 15(2). 119–127. 1 indexed citations
7.
Lippa, Natalie, et al.. (2023). Clinical utility of exome sequencing in a pediatric epilepsy cohort. Epilepsia. 64(4). 986–997. 10 indexed citations
8.
Ahimaz, Priyanka, et al.. (2023). Genetic counselors' utilization of ChatGPT in professional practice: A cross‐sectional study. American Journal of Medical Genetics Part A. 194(4). e63493–e63493. 5 indexed citations
9.
Sheidley, Beth Rosen, Jennifer Malinowski, Amanda L. Bergner, et al.. (2021). Genetic testing for the epilepsies: A systematic review. Epilepsia. 63(2). 375–387. 67 indexed citations
10.
Bergner, Amanda L., et al.. (2021). The evolution of genetic counseling graduate education in New York City during the COVID‐19 pandemic: In the eye of the storm. Journal of Genetic Counseling. 30(4). 1057–1068. 5 indexed citations
11.
Radtke, Heather B., Amanda L. Bergner, Allison L. Goetsch, et al.. (2020). Genetic Counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis—Practice Resource of the National Society of Genetic Counselors. Journal of Genetic Counseling. 29(5). 692–714. 15 indexed citations
12.
Bergner, Amanda L., Chris Halpin, Vanessa L. Merker, et al.. (2018). Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2. Otology & Neurotology. 39(5). 632–638. 16 indexed citations
13.
Applegate, Carolyn, et al.. (2017). Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian disease. European Journal of Human Genetics. 25(5). 530–537. 27 indexed citations
14.
Blakeley, Jaishri O., Xiaobu Ye, Dan G. Duda, et al.. (2016). Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas. Journal of Clinical Oncology. 34(14). 1669–1675. 86 indexed citations
15.
Merker, Vanessa L., Amanda L. Bergner, Ana-Maria Vranceanu, et al.. (2016). Health-related Quality of Life of Individuals With Neurofibromatosis Type 2. Otology & Neurotology. 37(5). 574–579. 17 indexed citations
16.
Rhodes, Steven D., Wei Zhang, Dalong Yang, et al.. (2015). Dystrophic Spinal Deformities in a Neurofibromatosis Type 1 Murine Model. PLoS ONE. 10(3). e0119093–e0119093. 7 indexed citations
17.
Vargas, Wendy, Linda Heier, Fausto J. Rodríguez, Amanda L. Bergner, & Kaleb Yohay. (2014). Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2. NeuroImage Clinical. 4. 258–265. 2 indexed citations
18.
Bergner, Amanda L., et al.. (2012). Increased risk of breast cancer in women with NF1. American Journal of Medical Genetics Part A. 158A(12). 3056–3060. 74 indexed citations
19.
Vernon, Hilary J., et al.. (2010). Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria. Molecular Genetics and Metabolism. 100(3). 229–233. 30 indexed citations
20.
Reis, Linda M., Rebecca C. Tyler, Omar Abdul‐Rahman, et al.. (2008). Mutation analysis of B3GALTL in Peters Plus syndrome. American Journal of Medical Genetics Part A. 146A(20). 2603–2610. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracy L. Trotter Breakdown of academic impact, for papers by Anuradha Ganesh Breakdown of academic impact, for papers by Thomas Morel Breakdown of academic impact, for papers by Winifred J. Hamilton Breakdown of academic impact, for papers by André B. Rietman Breakdown of academic impact, for papers by F. Albarel Breakdown of academic impact, for papers by Heidi Crayton Breakdown of academic impact, for papers by Michael van Trotsenburg Breakdown of academic impact, for papers by Melissa W. Ko Breakdown of academic impact, for papers by Qinglin Pei
Rankless by CCL
2026